Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.4.0.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 174,973 $ 193,598
Accounts receivable, net 204,479 193,875
Inventory 40,575 39,681
Prepaid expenses and other current assets 33,505 26,904
Total current assets 453,532 454,058
Property, plant and equipment, net 133,948 131,798
Intangible assets, net 625,405 638,152
In-process research and development 793,626 792,275
Goodwill 746,961 743,348
Investments, net 35,212 34,716
Other assets 4,522 4,841
Total assets 2,793,206 2,799,188
Current liabilities:    
Accounts payable 73,436 72,535
Accrued expenses 182,342 167,899
Current portion of lines of credit and notes payable 11,454 11,468
Total current liabilities 267,232 251,902
2033 Senior Notes and estimated fair value of embedded derivatives, net of discount 49,608 48,986
Deferred tax liabilities, net 202,680  
Deferred tax liabilities, net   226,036
Other long-term liabilities, principally deferred revenue and line of credit 275,812 292,470
Total long-term liabilities 528,100 567,492
Total liabilities 795,332 819,394
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 547,980,417 and 546,188,516 shares issued at March 31, 2016 and December 31, 2015, respectively 5,480 5,462
Treasury Stock - 586,760 and 1,120,367 shares at March 31, 2016 and December 31, 2015, respectively (1,911) (3,645)
Additional paid-in capital 2,728,264 2,705,385
Accumulated other comprehensive loss (17,110) (22,537)
Accumulated deficit (716,849) (704,871)
Total shareholders’ equity 1,997,874 1,979,794
Total liabilities and equity $ 2,793,206 $ 2,799,188